Synthesis and Performance of Deep-Red Phosphorescent Iridium Complexes with Pyrone as an Auxiliary Ligand.

Wen Jiang, Wenming Hou, Caixian Yan, Zhifeng Nie, Qiaowen Chang, Xiangguang Li, Weiping Liu

Abstract read

In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Synthesis, Photo-Physical Properties, and Electroluminescence Characteristics of Iridium Phosphorescent Materials Based on Different β-Diketonate Ancillary Ligands.Molecules (Basel, Switzerland) · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wen JiangKunming Institute of Precious Metals, Yunnan Precious Metals Laboratory Co., Ltd., Kunming 650106, China.

Wenming HouSino-Platinum Metals Chemical (Yunnan) Co., Ltd., Kunming 650503, China.

Caixian YanKunming Institute of Precious Metals, Yunnan Precious Metals Laboratory Co., Ltd., Kunming 650106, China.

Zhifeng NieYunnan Key Laboratory of Metal-Organic Molecular Materials and Device, School of Chemistry and Chemical Engineering, Kunming University, Kunming 650214, China.

Qiaowen ChangKunming Institute of Precious Metals, Yunnan Precious Metals Laboratory Co., Ltd., Kunming 650106, China.

Xiangguang LiYunnan Key Laboratory of Metal-Organic Molecular Materials and Device, School of Chemistry and Chemical Engineering, Kunming University, Kunming 650214, China.

Weiping LiuKunming Institute of Precious Metals, Yunnan Precious Metals Laboratory Co., Ltd., Kunming 650106, China.

Funding

Frontier Research Team of Kunming University 2023, the High-Level Talent Plans for Young Top-notch Talents of Yunnan Province YNWR-ONBJ-2020017High-Level Talent Special Support Plans for Young Talents of Kunming City C201905002, C202014001National Natural Science Foundation of China 22065019Scientific Research Funds of Kunming University XPZJ2205, XPZJ2205-2Special Basic Cooperative Research Programs of Yunnan Provincial Undergraduate Universities' Association 202101BA070001-032Techonlogy Project of Yunnan Precious Metals Laboratory YPML2023050235the Program for Young and Middle-aged Academic and Technical Leaders Reserve Talents of Yunnan Province 202105AC160043Yunnan Fundamental Research Projects 202401AS070021

6 · The paper itself

Abstract

Two bis-cyclometalated heteroleptic iridium complexes incorporating 1-phenylisoquinoline (piq) as the main cyclometalating ligand and 3-hydroxy-2-methyl-4-pyrone (ma) or 2-ethyl-3-hydroxy-4H-pyran-4-one (ema) as the auxiliary ligand, namely Ir(piq)

Indexed as

deep rediridium complexphosphorescent organic light-emitting diode (PhOLED)pyrone

Identifiers

PMID38999135

DOI10.3390/molecules29133183

PMCPMC11242998

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.